﻿<?xml version="1.0" encoding="utf-8"?><?xml-stylesheet title="XSL_formatting" type="text/xsl" href="cms1260795.aspx"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><language>en-gb</language><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><lastBuildDate>Thu, 08 Jan 2009 19:20:39 GMT</lastBuildDate><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><description><![CDATA[aidsmap.com news feed : aidsmap news]]></description><copyright>Copyright NAM 2008</copyright><link>http://www.aidsmap.com</link><atom:link href="http://www.aidsmap.com/cms1260794.aspx" rel="self" type="application/rss+xml" /><image><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><url>http://www.aidsmap.com/files/file1002517.gif</url><link>http://www.aidsmap.com</link><width>122</width><height>44</height></image><ttl>15</ttl><item><title><![CDATA[US Health Department identifies further 18 effective HIV prevention programmes]]></title><link>http://www.aidsmap.com/en/news/19086F18-1287-46E6-940C-0873BD788212.asp</link><author>Gus Cairns</author><guid isPermaLink="false">19086F18-1287-46E6-940C-0873BD788212</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[The Centers for Disease Control and Prevention (CDC), the public-health branch of the US Department of Health and Human Services, have identified 18 more HIV prevention programmes whose efficacy stands up to scientific scrutiny well enough for them to be recommended. This brings the total number of officially ‘effective’ interventions to 57.
]]></description><category></category></item><item><title><![CDATA[More African people acquiring HIV in the UK than previously thought]]></title><link>http://www.aidsmap.com/en/news/176960DF-D01A-42CD-9105-EA0D8D44B86F.asp</link><author>Roger Pebody</author><guid isPermaLink="false">176960DF-D01A-42CD-9105-EA0D8D44B86F</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[The number of African people who acquire their HIV infection in the UK (rather than in Africa) is greater than national surveillance data indicate, report researchers in the January 14th issue of AIDS. Based on a study in London, they suggest that between a quarter and a third of HIV-positive African people were infected in the United Kingdom. Moreover, among HIV-positive African men who have sex with men, almost half acquired their infection in the UK. The authors therefore argue that HIV prevention interventions for Africans must focus on reducing transmission within the UK as well as addressing infections acquired abroad.
]]></description><category>UK news</category><category>Prevention news</category></item><item><title><![CDATA[HIV prevalence may decline because the most vulnerable are infected and die first]]></title><link>http://www.aidsmap.com/en/news/AD7F6011-6C98-445C-806F-6D68B12ACC04.asp</link><author>Gus Cairns</author><guid isPermaLink="false">AD7F6011-6C98-445C-806F-6D68B12ACC04</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[The declines in HIV prevalence and incidence seen in recent years in some countries may be largely due to differences in people’s susceptibility to the virus rather than behaviour change, according to a mathematical model based on a survey of Kenyan sex workers, published in the January 14th edition of AIDS. 
]]></description><category>Africa news</category><category>Statistics and epidemiology news</category><category>Prevention news</category></item><item><title><![CDATA[Lack of perceived need for HIV treatment associated with poor adherence]]></title><link>http://www.aidsmap.com/en/news/0571EA7C-7B32-4C2A-9B5D-221343928684.asp</link><author>Michael Carter</author><guid isPermaLink="false">0571EA7C-7B32-4C2A-9B5D-221343928684</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[Patients who do not think they need antiretroviral therapy have poorer adherence to such treatment, Dutch investigators report in the December 1st edition of the Journal of Acquired Immune Deficiency Syndromes. The investigators also found that a higher CD4 cell count was associated with a lower perceived necessity to start HIV treatment and theycomment “this finding…is relevant for the debate regarding the possibility of starting earlier with [antiretroviral therapy], that is, at a CD4 cell count of 500 cells per microliter.”
]]></description><category>Adherence news</category><category>Starting treatment news</category></item><item><title><![CDATA[TB doesn't always increase HIV viral load]]></title><link>http://www.aidsmap.com/en/news/74FB86D5-5BCD-400F-A8A7-267F075D704B.asp</link><author>Michael Carter</author><guid isPermaLink="false">74FB86D5-5BCD-400F-A8A7-267F075D704B</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[A quarter of Ugandan HIV-positive patients with active tuberculosis (TB) had a viral load below 10,000 copies/ml, investigators report in a letter published in the December 1st edition of the Journal of Acquired Immune Deficiency Syndromes. Furthermore, the investigators found that viral load increased in a significant proportion of patients whose viral load was below 1000 copies/ml after they started treatment with anti-TB drugs.
]]></description><category>Africa news</category><category>Tuberculosis news</category></item><item><title><![CDATA[New 75mg darunavir tablet approved by FDA for use by HIV-positive children]]></title><link>http://www.aidsmap.com/en/news/510351C1-B9D5-484B-B9F7-2BCA26B45306.asp</link><author>Michael Carter</author><guid isPermaLink="false">510351C1-B9D5-484B-B9F7-2BCA26B45306</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[Drug regulatory authorities in the US have approved a new 75mg darunavir (Prezista tablet for paediatric use. 
]]></description><category>New drugs news</category><category>Children and HIV news</category></item><item><title><![CDATA[Thyroid checks recommended for people with HIV]]></title><link>http://www.aidsmap.com/en/news/EBC26DAC-C874-4B44-B182-BFA9B21F6E24.asp</link><author>Michael Carter</author><guid isPermaLink="false">EBC26DAC-C874-4B44-B182-BFA9B21F6E24</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[Patients receiving HIV treatment should have routine tests to check thyroid function, doctors from the UK recommend in an article published in the January 1st  edition of the Journal of Acquired Immune Deficiency Syndromes. Investigators from London’s Chelsea and Westminster Hospital found “a higher than expected incidence of hypothyroidism” (an under-active thyroid gland) amongst their patients. 
]]></description><category>Medical tests news</category></item><item><title><![CDATA[Knighthood for head of UK HIV charity]]></title><link>http://www.aidsmap.com/en/news/E8FCD748-C685-4E90-A832-C4E5A50EFC88.asp</link><author>Michael Carter</author><guid isPermaLink="false">E8FCD748-C685-4E90-A832-C4E5A50EFC88</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[Nick Partridge, head of the UK’s largest HIV charity has received a knighthood in the New Year’s Honours list.
]]></description><category>UK news</category></item><item><title><![CDATA[Gay men often not accessing PEP despite risk of HIV exposure]]></title><link>http://www.aidsmap.com/en/news/4B5B88F8-7140-457B-AFC8-CC7C9EA25ABA.asp</link><author>Michael Carter</author><guid isPermaLink="false">4B5B88F8-7140-457B-AFC8-CC7C9EA25ABA</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[Gay men may not be accessing HIV post-exposure prophylaxis (PEP) in situations when its use would be warranted, a study published in the online edition of Sexually Transmitted Infections suggests. 
]]></description><category>UK news</category><category>Gay men news</category><category>Prevention news</category></item><item><title><![CDATA[Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV]]></title><link>http://www.aidsmap.com/en/news/025FC859-1838-422E-97CA-F503636D4E4B.asp</link><author>Kelly Safreed-Harmon</author><guid isPermaLink="false">025FC859-1838-422E-97CA-F503636D4E4B</guid><pubDate>Thu, 08 Jan 2009 19:20:39 GMT</pubDate><image /><description><![CDATA[A study published in the December 15th edition of the Journal of Acquired Immune Deficiency Syndromes has provided further insight into the relationship between HIV and heart disease by examining factors associated with endothelial activation. The study found higher than normal endothelial activation levels in HIV-positive people who are not taking antiretroviral therapy, but there was no evidence of an association between endothelial activation and lipoatrophy, which other researchers have suggested may be a risk factor for heart disease in HIV-positive people.
]]></description><category>Lipodystrophy news</category></item></channel></rss>